Rowan University and Sentrimed®, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced results from...
oral
Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group...
Study selectionThe bibliometric searches yielded numerous duplicates and records unrelated to the topic. After screening and thoroughly reading the full...
Newswise — Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to...
Healthcare workers at nursing homes face a major challenge when helping older adults to maintain their oral hygiene. This has...
Students from 13 schools completed the survey, resulting in a school response rate of 68.4%, showing a strong representation of...
